Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disease-modifying therapy in multiple sclerosis: recommendations of Multiple Sclerosis and Neuroimmunology Section of Polish Neurological Society.
Kułakowska A, Mirowska-Guzel D, Kalinowska A, Bartosik-Psujek H, Brola W, Stasiolek M, Głąbiński A, Losy J, Potemkowski A, Rejdak K, Sarzyńska-Długosz I, Siger M, Stępień A, Wawrzyniak S, Zaborski J, Zakrzewska-Pniewska B, Adamczyk-Sowa M. Kułakowska A, et al. Among authors: wawrzyniak s. Neurol Neurochir Pol. 2024;58(6):569-585. doi: 10.5603/pjnns.102356. Neurol Neurochir Pol. 2024. PMID: 39737584 Free article.
Update on diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - recommendations of Section of Multiple Sclerosis and Neuroimmunology of Polish Neurological Society.
Zakrzewska-Pniewska B, Bartosik-Psujek H, Brola W, Gołębiowski M, Kalinowska A, Kułakowska A, Mirowska-Guzel D, Nojszewska M, Podlecka-Piętowska A, Stasiołek M, Wawrzyniak S, Adamczyk-Sowa M. Zakrzewska-Pniewska B, et al. Among authors: wawrzyniak s. Neurol Neurochir Pol. 2024 Dec 18. doi: 10.5603/pjnns.100945. Online ahead of print. Neurol Neurochir Pol. 2024. PMID: 39692818 Free article.
Multiple sclerosis and autoimmune diseases - a case control study.
Wawrzyniak S, Rakoca M, Kułakowska A, Bartosik-Psujek H, Koziarska D, Kapica-Topczewska K, Kubicka-Bączyk K, Adamczyk-Sowa M. Wawrzyniak S, et al. Neurol Neurochir Pol. 2023;57(4):344-351. doi: 10.5603/PJNNS.a2023.0038. Epub 2023 Jun 21. Neurol Neurochir Pol. 2023. PMID: 37341190 Free article.
No Motor Costs of Physical Education with Eduball.
Cichy I, Kruszwicka A, Przybyla T, Rochatka W, Wawrzyniak S, Klichowski M, Rokita A. Cichy I, et al. Among authors: wawrzyniak s. Int J Environ Res Public Health. 2022 Nov 22;19(23):15430. doi: 10.3390/ijerph192315430. Int J Environ Res Public Health. 2022. PMID: 36497505 Free PMC article.
Symptoms after COVID-19 Infection in Individuals with Multiple Sclerosis in Poland.
Czarnowska A, Kapica-Topczewska K, Zajkowska O, Adamczyk-Sowa M, Kubicka-Bączyk K, Niedziela N, Warmus P, Kalinowska-Łyszczarz A, Kania K, Słowik A, Wnuk M, Marona M, Nowak K, Bartosik-Psujek H, Lech B, Perenc A, Popiel M, Kucharska-Lipowska M, Chorąży M, Tarasiuk J, Mirończuk A, Kochanowicz J, Lasek-Bal A, Puz P, Maciejowska K, Wawrzyniak S, Niezgodzińska-Maciejek A, Pokryszko-Dragan A, Gruszka E, Budrewicz S, Białek M, Zwiernik J, Michałowska A, Nosek K, Zwiernik B, Lewańczyk B, Brola W, Kułakowska A. Czarnowska A, et al. Among authors: wawrzyniak s. J Clin Med. 2021 Nov 10;10(22):5225. doi: 10.3390/jcm10225225. J Clin Med. 2021. PMID: 34830507 Free PMC article.
Modified Rio Score with Platform Therapy Predicts Treatment Success with Fingolimod and Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients.
Jamroz-Wiśniewska A, Zajdel R, Słowik A, Marona M, Wnuk M, Adamczyk-Sowa M, Adamczyk B, Lasek-Bal A, Puz P, Stęposz A, Krzystanek E, Patalong-Ogiewa M, Pokryszko-Dragan A, Budrewicz S, Koziarska D, Karbicka A, Wawrzyniak S, Fryze W, Furtak-Niczyporuk M, Rejdak K. Jamroz-Wiśniewska A, et al. Among authors: wawrzyniak s. J Clin Med. 2021 Apr 22;10(9):1830. doi: 10.3390/jcm10091830. J Clin Med. 2021. PMID: 33922368 Free PMC article.
38 results